Literature DB >> 6229206

Immunologic abnormalities in patients receiving multiple blood transfusions.

P Gascón, N C Zoumbos, N S Young.   

Abstract

Concern for the potential risk of the acquired immunodeficiency syndrome among blood cell recipients led us to measure immunologic functions in patients who had received multiple transfusions. Abnormalities of two immunologic tests, natural killer cell function and helper/suppressor (T4/T8) lymphocyte subpopulation ratio, have characterized patients with the acquired immunodeficiency syndrome and are prevalent in populations at risk for this syndrome. Natural killer cell function was severely depressed in multiply transfused patients. However, T4/T8 ratios were normal in this population. The role of chronic antigenic stimulation was studied by measurement of HLA-DR expression on T cells. The expression of HLA-DR antigen is markedly elevated in multiply transfused patients. These results show that chronic exposure to foreign antigens may be associated with abnormalities of immunologic function, but that chronically transfused patients do not have the same immunologic profile as reported in some homosexuals and hemophiliacs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6229206     DOI: 10.7326/0003-4819-100-2-173

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  47 in total

1.  Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.

Authors:  Keerati Charoencholvanich; Pichet Siriwattanasakul
Journal:  Clin Orthop Relat Res       Date:  2011-04-22       Impact factor: 4.176

2.  Perioperative measurements of IL-6 and α-melanocyte stimulating hormone in a cardiac transplant patient after ventricular assist device support.

Authors:  T Sakai; A Kudoh; N Kotani; T W Latson; A H Giesecke; A Matsuki
Journal:  J Anesth       Date:  1995-03       Impact factor: 2.078

Review 3.  Non-continuous versus continuous wound drainage after total knee arthroplasty: a meta-analysis.

Authors:  Tao Li; Qianyu Zhuang; Xisheng Weng; Lei Zhou; Yanyan Bian
Journal:  Int Orthop       Date:  2013-09-19       Impact factor: 3.075

4.  Prospective randomized controlled trial investigating the type of sutures used during hepatectomy.

Authors:  Norifumi Harimoto; Ken Shirabe; Tomoyuki Abe; Takafumi Yukaya; Eiji Tsujita; Tomonobu Gion; Kiyoshi Kajiyama; Takashi Nagaie
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

5.  A systematic study of host defense processes in badly injured patients.

Authors:  H C Polk; C D George; S R Wellhausen; K Cost; P R Davidson; M P Regan; A P Borzotta
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

6.  Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human blood.

Authors:  M J Dobersen; P Gascon; S Trost; J A Hammer; S Goodman; A B Noronha; D J O'Shannessy; R O Brady; R H Quarles
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Effect of varying number and volume of transfusions on mortality rate following septic challenge in an animal model.

Authors:  J P Waymack; G D Warden; P Miskell; S Gonce; J W Alexander
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

Review 8.  Recent developments in the area of massive transfusion.

Authors:  J A Collins
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

9.  Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery.

Authors:  Madhulika Sharma; Nirmal Kumar Ganguly; Gaurav Chaturvedi; Shyam K S Thingnam; Siddhartha Majumdar; Rajendar Krishan Suri
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

10.  [Effect of perioperative donor blood transfusion on prognosis of bronchial cancer].

Authors:  T Zimmermann; J Dobroschke; C Becker; C Kelm; W M Padberg
Journal:  Langenbecks Arch Chir       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.